191 related articles for article (PubMed ID: 33960697)
1. The efficacy of radiofrequency ablation versus cryoablation in the treatment of single hepatocellular carcinoma: A population-based study.
Chen L; Ren Y; Sun T; Cao Y; Yan L; Zhang W; Ouyang T; Zheng C
Cancer Med; 2021 Jun; 10(11):3715-3725. PubMed ID: 33960697
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of percutaneous ethanol injection versus radiofrequency ablation for single hepatocellular carcinoma no larger than 5 cm.
Yang P; Li N
J Int Med Res; 2022 Jul; 50(7):3000605221111281. PubMed ID: 35861264
[TBL] [Abstract][Full Text] [Related]
3. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of surgery in advanced hepatocellular carcinoma: a cohort study.
Chen L; Sun T; Chen S; Ren Y; Yang F; Zheng C
World J Surg Oncol; 2020 Jun; 18(1):119. PubMed ID: 32487104
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency Ablation
Xu J; Noda C; Erickson A; Mokkarala M; Charalel R; Ramaswamy R; Tao YU; Akinwande O
Anticancer Res; 2018 Nov; 38(11):6381-6386. PubMed ID: 30396961
[TBL] [Abstract][Full Text] [Related]
6. Differences in Survival Between First-Line Radiofrequency Ablation versus Surgery for Early-Stage Hepatocellular Carcinoma: A Population Study Using the Surveillance, Epidemiology, and End Results Database.
Lin Y; Pan XB
Med Sci Monit; 2020 May; 26():e921782. PubMed ID: 32461542
[TBL] [Abstract][Full Text] [Related]
7. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma.
Wang C; Wang H; Yang W; Hu K; Xie H; Hu KQ; Bai W; Dong Z; Lu Y; Zeng Z; Lou M; Wang H; Gao X; Chang X; An L; Qu J; Li J; Yang Y
Hepatology; 2015 May; 61(5):1579-90. PubMed ID: 25284802
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Saudi J Gastroenterol; 2018; 24(6):317-325. PubMed ID: 30117492
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
10. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
13. The Efficacy of Surgical Resection versus Radiofrequency Ablation for the Treatment of Single Hepatocellular Carcinoma: A SEER-Based Study.
Wu F; Wei C; Zhang S; Jia S; Zhang J
Gastroenterol Res Pract; 2023; 2023():1269504. PubMed ID: 36865983
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma ≤ 4 cm treated with radiofrequency ablation with or without percutaneous ethanol injection.
Shi F; Tan Z; An H; Wang X; Xu Y; Wang S
Ann Hepatol; 2016; 15(1):61-70. PubMed ID: 26626642
[TBL] [Abstract][Full Text] [Related]
15. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma.
Kim N; Kim HJ; Won JY; Kim DY; Han KH; Jung I; Seong J
Radiother Oncol; 2019 Feb; 131():81-87. PubMed ID: 30773192
[TBL] [Abstract][Full Text] [Related]
17. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
18. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
[TBL] [Abstract][Full Text] [Related]
19. Surgical resection versus radiofrequency ablation very early-stage HCC (≤2 cm Single HCC): A propensity score analysis.
Chu HH; Kim JH; Kim PN; Kim SY; Lim YS; Park SH; Ko HK; Lee SG
Liver Int; 2019 Dec; 39(12):2397-2407. PubMed ID: 31549771
[TBL] [Abstract][Full Text] [Related]
20. Comparison among cryoablation, radiofrequency ablation, and partial nephrectomy for renal cell carcinomas sized smaller than 2 cm or sized 2-4 cm: A population-based study.
Yan S; Yang W; Zhu CM; Yan PM; Wang ZC
Medicine (Baltimore); 2019 May; 98(21):e15610. PubMed ID: 31124938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
